PCSK9 inhibitors in a renal transplant patient complicated with hepatitis B: A case report and literature review

Lipid metabolism disorders are recognized to be one of the most frequent complications of renal transplantation, while dyslipidemia and chronic kidney disease (CKD) are strong risk factors for arteriosclerotic cardiovascular disease (ASCVD). Proprotein convertase subtilisin/kexin type 9 inhibitors (...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Pinchao, Li, Yuxi, Wu, Lin, Weng, Haoyu, Chen, Ming, Ding, Wenhui, Li, Jianping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676271/
https://www.ncbi.nlm.nih.gov/pubmed/36419496
http://dx.doi.org/10.3389/fcvm.2022.937474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676271/
https://www.ncbi.nlm.nih.gov/pubmed/36419496
http://dx.doi.org/10.3389/fcvm.2022.937474

Ejemplares similares